Literature DB >> 24669910

The inhibitory effect of salvianolic acid B on TGF-β1-induced proliferation and differentiation in lung fibroblasts.

Min Zhang1, Shu-Ren Cao, Rui Zhang, Jin-Lan Jin, You-Feng Zhu.   

Abstract

Salvianolic acid B (Sal B), one of the major water-soluble compounds of Danshen (a popular Chinese herb), possesses many of the biological activities, such as antifibrogenic effect in liver and renal diseases. Transforming growth factor-β1 (TGF-β1) plays a central role in the development of pulmonary fibrosis by stimulating extracellular matrix (ECM) accumulation and activating fibroblasts. Here, we investigated the effects of Sal B on cell proliferation, collagen synthesis, endogenous TGF-β1 production, and α-smooth muscle actin (α-SMA, a marker of myofibroblasts) expression in human lung fibroblasts stimulated by TGF-β1 in vitro. The cell proliferation rates were analyzed by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide) assay. The expression of TGF-β1 and type I collagen at both the mRNA and protein levels was detected by reverse transcription polymerase chain reaction (RT-PCR), enzyme-linked immunosorbent assay (ELISA), and radioimmunoassay, respectively. The α-SMA expression was detected by Western blot. TGF-β1 treatment of lung fibroblasts increased cell proliferation rates, and enhanced the expression level of type I collagen, endogenous TGF-β1 production, and α-SMA expression (P < .05). The treatment with only Sal B did not affect the proliferation and differentiation of lung fibroblasts. Interestingly, Sal B was found to inhibit TGF-β1-induced cell proliferation, expression of type I collagen, endogenous TGF-β1 production, and α-SMA expression in lung fibroblasts. Moreover, the inhibitory effect of Sal B on TGF-β1-induced proliferation and differentiation in lung fibroblasts was more significant when treated with high-dose Sal B (1 μmol/L versus 10 μmol/L, P < .05). These data demonstrate that Sal B inhibits TGF-β1-induced cell proliferation and differentiation in vitro experiment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24669910     DOI: 10.3109/01902148.2014.895070

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  8 in total

1.  Study on salvianolic acid B in the reduction of epidural fibrosis in laminectomy rats.

Authors:  Feng Chen; Zhenbo Zuo; Kai Wang; Chengdong Zhang; Haifeng Gong; Fagang Ye; Aiyu Ji; Hao Tao
Journal:  BMC Musculoskelet Disord       Date:  2014-10-07       Impact factor: 2.362

Review 2.  Traditional Chinese medicine for pulmonary fibrosis therapy: Progress and future prospects.

Authors:  Liu-Cheng Li; Lian-Di Kan
Journal:  J Ethnopharmacol       Date:  2016-12-28       Impact factor: 4.360

3.  Triptolide protects against TGF-β1-induced pulmonary fibrosis by regulating FAK/calpain signaling.

Authors:  Pingheng Zhang; Jian Liu; Ruikai Zong
Journal:  Exp Ther Med       Date:  2019-10-25       Impact factor: 2.447

Review 4.  Pharmacological Effects of Salvianolic Acid B Against Oxidative Damage.

Authors:  Zhun Xiao; Wei Liu; Yong-Ping Mu; Hua Zhang; Xiao-Ning Wang; Chang-Qing Zhao; Jia-Mei Chen; Ping Liu
Journal:  Front Pharmacol       Date:  2020-11-11       Impact factor: 5.810

5.  Exploring the Pharmacological Mechanism of Radix Salvia Miltiorrhizae in the Treatment of Radiation Pneumonia by Using Network Pharmacology.

Authors:  Peng Li; Xiaochun Xia; Jundong Zhou; Jinchang Wu
Journal:  Front Oncol       Date:  2021-07-29       Impact factor: 6.244

Review 6.  Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis.

Authors:  Cristina Estornut; Javier Milara; María Amparo Bayarri; Nada Belhadj; Julio Cortijo
Journal:  Front Pharmacol       Date:  2022-01-21       Impact factor: 5.810

7.  Rejuvenation by inhibiting TGF-β1/pSmad signaling.

Authors:  Elizabeth H Corder; Karta Purkh Singh Khalsa
Journal:  Oncotarget       Date:  2015-07-10

8.  Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report.

Authors:  Shuo-Wen Hung; Yuan-Ching Liao; I-Chang Chi; Ting-Yen Lin; Yu-Chuan Lin; Hung-Jen Lin; Sheng-Teng Huang
Journal:  Explore (NY)       Date:  2021-12-13       Impact factor: 1.775

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.